Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

25 (OH) vitamin D: High levels in serum (Risk) (76)

Source: Potential biomarkers associated with risk of developing PCa. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Scoping review.

Scoping review

Maps the extent and characteristics of research on a topic.

Meta-analysis unclear · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Research on potential biomarkers of prostate cancer in Latin America and the Caribbean: a scoping review

Source: Article title.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Research on potential biomarkers of prostate cancer in Latin America and the Caribbean: a scoping review

Scoping review · Frontiers in Oncology · 2026

Original publication title

Research on potential biomarkers of prostate cancer in Latin America and the Caribbean: a scoping review

Nicolas J Prada; Daniel Mendivelso-González; Sabrina Yepes; Carolay Corredor; Rafael Parra-Medina; Rodolfo Varela; Martha Lucía Serrano

Copyright © 2026 Prada, Mendivelso-González, Yepes, Corredor, Parra-Medina, Varela and Serrano.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Most studies analyzed the relationship between various potential biomarkers and the risk of developing PCa as well as its prognosis. The majority of studies came from continental countries with lower percentages of African ancestry and lower PCa mortality rates, highlighting the need to strengthen research in LAC while improving access to healthcare. Systematic review registration:

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Latin America and the Caribbean (LAC) have higher prostate cancer (PCa) mortality rates than other regions, possibly due to disparities in detection and treatment, as well as differences in tumor biology and behavior. This scoping review aimed to identify studies conducted in LAC that evaluated potential biomarkers associated with PCa.

Source: Background

Abstract: What methods does the paper describe?

A search was conducted in PubMed, Scopus, Embase, LILACS, and Web of Science, including original studies conducted in LAC that evaluated the presence of potential biomarkers in relation to PCa. Due to the heterogeneity of the studies, a descriptive analysis of the data was performed.

Source: Methods

Abstract: Results

A total of 138 articles were included, evaluating 342 potential biomarkers across 17 countries/territories of LAC. Articles were classified into one or more of the following categories of potential biomarkers: risk of developing PCa (n=74), screening, early detection, and diagnosis (n=13), prognosis (n=48), treatment (n=10) and others (n=12). The countries with the most publications were Brazil, Mexico, and Chile.

Source: Results

Abstract: Conclusion

Most studies analyzed the relationship between various potential biomarkers and the risk of developing PCa as well as its prognosis. The majority of studies came from continental countries with lower percentages of African ancestry and lower PCa mortality rates, highlighting the need to strengthen research in LAC while improving access to healthcare. Systematic review registration:

Source: Conclusion
Authors’ abstract

Background

Latin America and the Caribbean (LAC) have higher prostate cancer (PCa) mortality rates than other regions, possibly due to disparities in detection and treatment, as well as differences in tumor biology and behavior. This scoping review aimed to identify studies conducted in LAC that evaluated potential biomarkers associated with PCa.

Methods

A search was conducted in PubMed, Scopus, Embase, LILACS, and Web of Science, including original studies conducted in LAC that evaluated the presence of potential biomarkers in relation to PCa. Due to the heterogeneity of the studies, a descriptive analysis of the data was performed.

Results

A total of 138 articles were included, evaluating 342 potential biomarkers across 17 countries/territories of LAC. Articles were classified into one or more of the following categories of potential biomarkers: risk of developing PCa (n=74), screening, early detection, and diagnosis (n=13), prognosis (n=48), treatment (n=10) and others (n=12). The countries with the most publications were Brazil, Mexico, and Chile.

Conclusion

Most studies analyzed the relationship between various potential biomarkers and the risk of developing PCa as well as its prognosis. The majority of studies came from continental countries with lower percentages of African ancestry and lower PCa mortality rates, highlighting the need to strengthen research in LAC while improving access to healthcare. Systematic review registration:

Publication and source details

Original title: Research on potential biomarkers of prostate cancer in Latin America and the Caribbean: a scoping review

Nicolas J Prada; Daniel Mendivelso-González; Sabrina Yepes; Carolay Corredor; Rafael Parra-Medina; Rodolfo Varela; Martha Lucía Serrano

Frontiers in Oncology · 2026

* Correspondence: Martha Lucía Serrano, mlserranol@unal.edu.coCopyright © 2026 Prada, Mendivelso-González, Yepes, Corredor, Parra-Medina, Varela and Serrano.2026Prada, Mendivelso-González, Yepes, Corredor, Parra-Medina, Varela and Serranohttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.The author(s) declared that financial support was received for this work and/or its publication. This study was supported and funded by the Instituto Nacional de Cancerología (INC) of Colombia.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T00:15:37.895592+00:00

DOI: 10.3389/fonc.2026.1740352 · PMC12900684